Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients:Effect of treatment

作     者：G Vijayan RC Sundaram Zachariah Bobby Abdoul Hamide N Selvaraj N Rattina Dasse 

作者机构：Department of Biochemistry Jawaharlal Institute of Postgraduate Medical Education and Research Pondicherry 605006 India Department of Medicine Jawaharlal Institute of Postgraduate Medical Education and Research Pondicherry 605006 India 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2007年第13卷第5期

页      面：796-800页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：幽门螺杆菌感染 贫血 果糖胺 丙二醛 血浆含量 

摘      要：AIM: To unravel the possible association of malon-dialdehyde (MDA) and fructosamine in anemic H pylori infected patients and to observe the alteration in MDA and fructosamine levels in these patients after treatment for one ***: Fructosamine, MDA and glucose were estimated in 22 anemic H pylori infected patients and 16 healthy controls. Hematological parameters were also evaluated in both the groups using Sysmex-K-100 automated cell counter. The H pylori infected patients were randomly divided into two groups. H pylori infected patients in GroupⅠreceived both iron supplementation and anti-H pylori therapy, while patients in Group Ⅱ received only iron supplementation. All the biochemical and hematological parameters were estimated after one month of treatment. RESULTS: In anemic H pylori infected patients, while MDA (5.41 ± 2.16 vs 2.26 ± 0.50; P 0.05) and fructosamine (2.64 ± 0.93 vs 1.60 ± 0.35; P 0.05) were significantly increased, iron (32.72 ± 14.93 vs 110.25 ± 26.58; P 0.05), hemoglobin (6.9 ± 2.6 vs 12.66 ± 0.74; P 0.05) and ferritin (28.82 ± 16.27 vs 140.43 ± 30.72; P 0.05) levels were significantly decreased compared with the controls. With partial correlation analysis, fructosamine was found to have a significant positive correlation with MDA. In GroupⅠ, while MDA level decreased significantly (3.11 ± 1.73 vs 5.50 ± 2.46; P 0.05), there was a significant increase in iron (84.09 ± 29.51 vs 36.09 ± 17.81; P 0.05), hemoglobin (10.40 ± 1.11 vs 7.42 ± 1.90; P 0.05) and ferritin (116.91 ± 63.34 vs 30.46 ± 17.81; P 0.05) levels after one month. There was no significant change in the levels of fructosamine in groupⅠafter treatment. Similarly, no significant alterations were noted in the levels of MDA, fructosamine, hemoglobin or ferritin in Group Ⅱ patients after one month of ***: An increased level of fructosamine and MDA was found in anemic H pylori infected patients. Present data supports the premise that lipid peroxi